iBio receives patent allowances for pandemic influenza therapeutics
iBio intellectual property vice president Dr Wayne P. Fitzmaurice noted that the antibodies covered by these patents are designed to block critical functions of the influenza virus necessary
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.